Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone

First study of Janssen's prime-boost vaccine regimen in an Ebola outbreak country
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news